Mental health startup YLAH closes first funding round

The “blended psychotherapy” approach is widely considered to have great potential. Professionals can digitally assign patients personalised support and small tasks between sessions. Patients can engage with their mental health between face-to-face appointments. The approach also supports them in integrating therapeutic activities into their daily lives. Experts consider this hybrid approach more effective and efficient than sessions alone or pure online therapy.

Privatklinik Wyss AG (PKW) has been using state-of-the-art, clinically validated and personalised therapy services for years and already has experience with blended psychotherapy. PKW and YLAH will be joining forces from May 2023. Going forward, YLAH’s therapy platform will be evaluated by doctors and psychologists working at PKW.

Florence von Gunten, the CEO of YLAH AG and the person behind the project, is delighted with the partnership: “In Privatklinik Wyss AG, we have gained a strong partner to work alongside us. For more than a year, we have been gathering input from future customers and involving them in our development, thus ensuring that YLAH is developed in line with their needs.”

“As a clinic, we are interested in using a scientifically validated product like YLAH to increase the efficiency and effectiveness of therapy. My team and I have already validated the YLAH prototype and are very satisfied with the development so far”, says Christian Imboden, MD, Medical Director and Chairman of the Clinic Management of Privatklink Wyss AG and clinical advisor for YLAH.

Support on strategic level

PKW cooperates with YLAH not only on the clinical and operational level, but also on the strategic level. Markus Wyss, sixth-generation clinic owner, supports the YLAH team strategically and has been a member of the YLAH Board of Directors since January 2023. Wyss is also thrilled about the partnership: “Privatklinik Wyss has been driving digitalisation forward for years. This cooperation with YLAH gives us the unique opportunity to use the expertise of the clinic’s specialists to co-develop a solution that is tailored to both patients and practitioners."

First funding round

In addition to the partnership YLAH announced the closing of its first funding round. YLAH AG successfully closed the pre-seed financing round in January and will use the funding to continue to drive product development in the coming months. A clickable prototype was already tested with end users in 2022. The insights and feedback gained are currently being incorporated into the development of the YLAH platform. The first version of the therapy platform will be ready for testing in outpatient and inpatient settings in May 2023. The insights gained will be incorporated into the subsequent development cycles. The first therapy modules on the YLAH platform focus on depression, anxiety disorders and related treatment topics.

(Press release / SK)